ArticleClinical case reports2021
Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma.
Sewanti Limaye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it